Staar Surgical Shines In May; Stock Gains 28% On Restructuring Potential

Investors seeing upside earnings potential in Staar Surgical's May restructuring effort, management changes and new product milestones helped make the ophthalmic device firm's stock a star performer on Wall Street during the month. The issue jumped 28.2% to 13-5/8 in May, a 3-point gain.

More from Archive

More from Medtech Insight